# Nayam Innovations

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nayam-innovations

- Industry: Medical Devices & Equipment
- Headquarters: Pune, India
- Website: www.nayaminnovations.com
- Total disclosed funding: $3M
- Latest round: Series A (Jul 20, 2022)
- Investors on record: 4

## About

Nayam Innovations specializes in advanced intraocular lenses (IOLs) developed through a unique customization technology, aiming to enhance vision quality for cataract patients.Founded in 2012 in Pune, India, Nayam Innovations focuses on developing advanced intraocular lenses. The company has made significant strides in its funding journey, raising INR 97.17 mn in a Series A funding round in July 2022, led by The Vinod Jain Family office, with participation from Bharat Innovation Fund, Indian Angel Network, and Pragnya Advisors. Co-founders Surendra Ponrathnam and Tanuj Gigras have an extensive background in innovation and technology, contributing to the company's growth. Currently, Nayam Innovations has raised a total of INR 97.17 mn with a current valuation of INR 1516.52 mn.Nayam Innovations Pvt. Ltd. develops advanced intraocular lenses (IOLs) using a unique customization technology platform. Their flagship products, E-SITE™ and I-SITE™, aim to provide tailored solutions for patients undergoing cataract surgery, addressing various visual impairments. These lenses are marketed towards healthcare providers and surgical centers, facilitating spectacle-free LASIK-quality vision at all distances for cataract patients, particularly in regions with a high incidence of cataracts.In the most recent fiscal year of 2023, Nayam Innovations reported zero revenue and an EBITDA of INR -295,810.8. The company's revenue model is based on the direct sale of customized intraocular lenses to healthcare providers and surgical centers, ensuring affordability for patients while leveraging innovative technology in their products.Following their Series A funding of INR 97.17 mn in July 2022, Nayam Innovations plans to complete human clinical trials to validate the safety and efficacy of their products. This is a crucial step towards launching their offerings in India and expanding into international markets, including the US, Europe, Singapore, China, and Japan. The recent funding will support these initiatives, enabling Nayam to enhance its market presence and customer engagement.

## Funding rounds

- Series A, Jul 20, 2022, $1.2M — Pragnya Advisors, Indian Angel Network, Bharat Innovation Fund, The Vinod Jain Family office
- Series A, Sep 30, 2021, $1.8M — Pragnya Advisors, Indian Angel Network, Bharat Innovation Fund

## Investors

- Pragnya Advisors — Series A
- Indian Angel Network (https://capitalatlas.ai/funds/indian-angel-network) — Series A
- Bharat Innovation Fund (https://capitalatlas.ai/funds/bharat-innovation-fund) — Series A
- The Vinod Jain Family office — Series A